Nervgen Pharma Corp.

NGEN Nasdaq SEC CIK 1751912
Follow Nervgen Pharma Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 CAD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing